Michael Aaron Kelly - Oct 19, 2022 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Carman Alenson attorney-in-fact
Stock symbol
PRME
Transactions as of
Oct 19, 2022
Transactions value $
$0
Form type
4
Date filed
10/21/2022, 04:30 PM
Previous filing
Jul 1, 2022
Next filing
May 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +9.01K $0.00 9.01K Oct 19, 2022 Common Stock 9.01K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in three equal annual installments beginning on September 13, 2022, subject to the Reporting Person's continued service on each such vesting date.